BioXcel Therapeutics
BTAI
#9513
Rank
A$40.53 M
Marketcap
$0.99
Share price
2.37%
Change (1 day)
-86.48%
Change (1 year)

BioXcel Therapeutics (BTAI) - Cash on Hand

Cash on Hand as of June 2024 : A$84.79 Million

According to BioXcel Therapeutics's latest financial reports the company has A$84.79 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

BioXcel Therapeutics - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31A$0.28 B-11.41%
2021-12-31A$0.32 B15.94%
2020-12-31A$0.27 B498.45%
2019-12-31A$46.31 M-23.35%
2018-12-31A$60.42 M5218.01%
2017-12-31A$1.13 M
2016-12-31N/A

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$0.43 B 408.98%๐Ÿ‡บ๐Ÿ‡ธ USA